We believe that our team is ultimately what will lead us to succeed.

Creating a brand in the industry with longevity requires a team that excels both individually and collectively.

At MCRG, our people and culture define the products that we deliver.

default

Thomas Kofman

Private Equity Partner & Financial Advisor

Tom has over 30 years of experience in Capital Markets on both the debt and equity side. Tom co-founded and ran M Partners, a full service institutional investment bank for the last 13 years. The bank has participated in over $5 billion dollars of transactions across the globe in numerous verticals since its inception. Through M Partners, the principals initiated many merchant banking transactions including one of the first public companies in the medical space in Canada (current market cap above $4 billion).

default

Warren Smulowitz

Private Equity Partner & Financial Advisor

Warren led a Wealth Management and Investment Banking practice at the Bank of Montreal from 2013 to 2018 before partnering with Tom to found Birch + Bond. He specialized in a hybrid investment banking platform while concentrating on alternative asset allocations, private equity investments, cash management and investment due diligence. Previously Warren consulted for a large multi billion dollar European family office where he assisted their investment banking platform in North America and was responsible for acquisitions, dispositions, asset management, due diligence, and debt and equity opportunities.

Steve-Nelham

Steve Nelham

President and Co-Founder of MCRG

Steve was born in Toronto, Ontario, and has gained business experience working for companies such as Sprint Canada as well as owning and managing his own Engineering business. Steve is very experienced in an ACMPR LP setup and he has in-depth knowledge of the medical industry’s benefits and opportunities. He has personally managed an LP from inception to completion and is one of the few people that have a comprehensive understanding of Health Canada’s legislated requirements. Steve is currently listed as an ACMPR Security Cleared Responsible Person in Charge.

Ryan-Kyle

Ryan Kyle

CEO and Co-Founder of MCRG

Originally from Huron County, Ryan is an entrepreneur with business experience in real estate. He is very knowledgeable of the industry and its process and products. As an entrepreneur, Ryan thrives on building relationships and establishing networks. Ryan has established connections with doctors, business personnel, export market customers, as well as other LPs in the area. As a recipient of many injuries in his part, Ryan personally understands the chronic pain individuals experience and is determined to help doctors and patients better understand the value of cannabinoid medicines.

Dr.-Daniel-Zavitz

Dr. Daniel Zavitz

Senior Research Scientist

Daniel has over 30 years experience teaching the sciences in tertiary and secondary educational institutions and over 20 year's of laboratory research experience in Physical and Analytical Chemistry. His passion for chemistry has been apparent throughout his career, which includes receiving a Ph.D in Physical Chemistry from the University of Illinois in 2011. Having published numerous papers and had extensive involvement in ensuring health and safety standards and quality assurance practices at his laboratories, Daniel brings a vast wealth of scientific and production knowledge to the industry.

Ken-Zardo

Ken Zardo

President of Reelax Pet Sciences Inc. & Major Accounts

Ken has spent the last two decades at the forefront of business consulting. With 25 years of innovative business leadership experience, he is a visionary, strategist and business entrepreneur. Ken’s overall success comes from working with long and short term projects with Public and Private companies within North America, contributing structure and process so groups are able to function effectively and make high quality decisions. Previous to MCRG, Ken was successful in launching a service business for a private equity firm to become their largest portfolio reaching over $200 Million within 3 years of inception.

Medical Cannabis Resource Group Investor Presentation